Loading...

FITC anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_FITC_1_110210
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_1_110210
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_2_110210
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
101206 500 µg SEK1109
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101205 50 µg SEK395
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  2. Moreno-García Á, et al. 2020. Biomolecules. 10:00. PubMed
  3. Xue F, et al. 2020. Int J Biol Sci. 2.105555556. PubMed
  4. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  5. Kiepura A, et al. 2021. Int J Mol Sci. 22:. PubMed
  6. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  7. Ostapoff K, et al. 2014. Cancer Res. 74:4966. PubMed
  8. Fan X, et al. 2015. Cancer Res. 75:86. PubMed
  9. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  10. Gupta P, Rajan M, Kulkarni S, et al. 2017. Int Immunopharmacol. 10.1016/j.intimp.2017.06.025. PubMed
  11. Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed
  12. Bijland S, et al. 2019. F1000Res. 8:117. PubMed
  13. Furuhashi K, et al. 2017. Immunology. 151:227. PubMed
  14. Miyatake Y, et al. 2018. J Immunol. 201:3051. PubMed
  15. Nesseler JP, et al. 2020. Cancers (Basel). 12: . PubMed
  16. Song R, et al. 2022. Immunology. 165:274. PubMed
  17. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  18. He D, et al. 2022. Immunity. 55:159. PubMed
  19. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  20. Du Y, et al. 2022. FASEB J. 36:e22248. PubMed
  21. van Dierendonck XAMH, et al. 2022. Proc Natl Acad Sci U S A. 119:e2114739119. PubMed
  22. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  23. Liu X, et al. 2022. Adv Sci (Weinh). 9:e2105650. PubMed
  24. Usui-Ouchi A, et al. 2022. Glia. 70:1762. PubMed
  25. Ocaña-Guzman R, et al. 2022. Cells. 11: . PubMed
  26. Li J, et al. 2022. FASEB J. 36:e22400. PubMed
  27. Dong H, et al. 2022. Proc Natl Acad Sci U S A. 119:e2123247119. PubMed
  28. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  29. Komori R, et al. 2022. Int J Mol Sci. 23: . PubMed
  30. Ostendorf BN, et al. 2022. Nature. 611:346. PubMed
  31. Shen Z, et al. 2022. EBioMedicine. 85:104285. PubMed
  32. Xuan FL, et al. 2022. Front Immunol. 13:1005067. PubMed
  33. Foo CX, et al. 2023. Eur Respir J. 61: . PubMed
  34. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  35. Shang T, et al. 2022. Front Pharmacol. 13:1054176. PubMed
  36. Roy S, et al. 2022. Am J Cancer Res. 12:4977. PubMed
  37. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  38. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  39. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  40. Miró L, et al. 2022. Cancers (Basel). 14: . PubMed
  41. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  42. Chen L, et al. 2022. Cancer Immunol Immunother. :. PubMed
  43. Chan L, et al. 2022. Cells. 12: . PubMed
  44. Wang L, et al. 2022. Nutrients. 15: . PubMed
  45. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  46. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  47. Li Y, et al. 2023. Cell Death Dis. 14:28. PubMed
  48. Freitag K, et al. 2023. Commun Biol. 6:40. PubMed
  49. Schmidt AD, et al. 2023. J Invest Dermatol. :. PubMed
  50. Jiang X, et al. 2023. Cell Discov. 9:7. PubMed
  51. Li B, et al. 2023. Nat Commun. 14:489. PubMed
  52. Schick J, et al. 2023. Elife. 12: . PubMed
  53. Zhu X, et al. 2023. Front Immunol. 14:1114802. PubMed
  54. Zhong CS, et al. 2022. Acta Pharmacol Sin. 43:1324. PubMed
  55. Mecklenburg J, et al. 2022. Brain Behav Immun. 101:246. PubMed
  56. Murotomi K, et al. 2022. Exp Biol Med (Maywood). 247:848. PubMed
  57. Zhao X, et al. 2022. Cell Mol Immunol. 19:540. PubMed
  58. Xin DQ, et al. 2022. Neural Regen Res. 17:2238. PubMed
  59. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  60. Tao X, et al. 2022. J Exp Med. 219:. PubMed
  61. Lopez R, et al. 2022. Nat Biotechnol. 40:1360. PubMed
  62. Gaikwad H, et al. 2022. ACS Nano. . PubMed
  63. Rybova J, et al. 2022. J Inherit Metab Dis. 45:1175. PubMed
  64. Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed
  65. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  66. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  67. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  68. Adzika GK, et al. 2023. Front Immunol. 14:1124649. PubMed
  69. Wang YC, et al. 2023. J Exp Med. 220:. PubMed
  70. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  71. Yang Y, et al. 2023. Cancers (Basel). 15:. PubMed
  72. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  73. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  74. Latour YL, et al. 2023. Gut Microbes. 15:2192623. PubMed
  75. Dona MSI, et al. 2023. Basic Res Cardiol. 118:11. PubMed
  76. Sun JY, et al. 2023. Sci Adv. 9:eade4110. PubMed
  77. Iguchi A, et al. 2023. iScience. 26:106375. PubMed
  78. Han S, et al. 2023. Int J Mol Sci. 24:. PubMed
  79. Zhu CL, et al. 2023. Int J Biol Sci. 19:1413. PubMed
  80. Thai LM, et al. 2023. iScience. 26:106477. PubMed
  81. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  82. Banka AL, et al. 2023. Nat Commun. 14:2462. PubMed
  83. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  84. Qin C, et al. 2023. iScience. 26:106588. PubMed
  85. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  86. Xu Y, et al. 2023. J Cancer. 14:1182. PubMed
  87. Feng X, et al. 2023. Nat Commun. 14:3208. PubMed
  88. Zhang Y, et al. 2023. NPJ Regen Med. 8:28. PubMed
  89. Chen SW, et al. 2023. Methods Mol Biol. 2683:53. PubMed
  90. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  91. Mawambo G, et al. 2023. J Neuroinflammation. 20:145. PubMed
  92. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  93. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  94. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  95. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  96. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  97. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  98. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  99. Zhao, Q., Li, J., et al. 2025. Nat Metab. 7(10),2099-2116. PubMed
  100. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  101. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  102. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  103. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  104. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  105. Belmonte L, et al. 2016. Sci Rep. 6:35813. PubMed
  106. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  107. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  108. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  109. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  110. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  111. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  112. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  113. Bo Yu et al. 2018. Cell stem cell. 23(2):193-209 . PubMed
  114. Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed
  115. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  116. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  117. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  118. Gan C, et al. 2022. Respir Res. 23:32. PubMed
  119. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  120. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  121. Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
  122. Tu S, et al. 2020. Cellular Signalling. 73:109695. PubMed
  123. Pandey S, et al. 2020. Cell Syst. 11:495. PubMed
  124. Tuominen S, et al. 2021. Eur J Nucl Med Mol Imaging. 48:1312. PubMed
  125. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  126. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  127. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  128. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  129. Wu G, et al. 2020. Front Oncol. 10:194. PubMed
  130. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  131. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
  132. Koning B, et al. 2006. Int Immunol. 1.403472222. PubMed
  133. Kapadia D, et al. 2011. PLoS One. 6:e19376. PubMed
  134. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  135. Zhang YS, et al. 2018. Cancer Biol Ther. 19:735. PubMed
  136. Poli V, et al. 2021. iScience. 24:103256. PubMed
  137. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  138. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  139. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  140. Zhu ZY, et al. 2022. Front Immunol. 12:781087. PubMed
  141. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  142. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  143. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  144. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  145. Chen S, et al. 2022. Cancer Discov. :. PubMed
  146. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  147. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  148. Stahnke S, et al. 2021. Current Biology. 31(10):2051-2064.e8. PubMed
  149. Zhang S, et al. 2021. Cell. 184(8):2151-2166.e16. PubMed
  150. Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
  151. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  152. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  153. Tong X, et al. 2020. Front Pharmacol. 1.404166667. PubMed
  154. Shang W, et al. 2019. J Diabetes Res. 2019:5641271. PubMed
  155. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  156. Lindborg JA et al. 2017. The Journal of Neuroscience. 37(43):10258-10277 . PubMed
  157. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  158. Duan M, et al. 2022. Cell Commun Signal. 20:60. PubMed
  159. Zhang Q, et al. 2021. Theranostics. 11:8301. PubMed
  160. Li B, et al. 2022. iScience. 25:103772. PubMed
  161. DeMarco JK, et al. 2021. Vaccines (Basel). 9:. PubMed
  162. Esmaili S, et al. 2021. Cell Systems. 12(5):432-445.e7. PubMed
  163. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  164. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  165. Yang C, et al. 2020. J Control Release. 326:324. PubMed
  166. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  167. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  168. Tanner MA, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H633. PubMed
  169. Caiado F, et al. 2013. Cancer Res. 73:4233. PubMed
  170. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  171. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  172. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  173. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  174. Siew JJ, et al. 2019. Nat Commun. 10:3473. PubMed
  175. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  176. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  177. Kasper M, et al. 2021. Elife. 10:. PubMed
  178. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  179. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  180. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  181. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  182. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  183. Periasamy S, et al. 2011. J Leukoc Biol. 90:493. PubMed
  184. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  185. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  186. Luo W, et al. 2019. Mol Med Rep. 20:1007. PubMed
  187. Mayers S, et al. 2019. BMC Biotechnol. 19:21. PubMed
  188. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  189. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  190. Kan C, et al. 2022. Bone Res. 10:62. PubMed
  191. Zhang J, et al. 2021. J Leukoc Biol. 110:485. PubMed
  192. Qiu F, et al. 2022. J Cancer. 13:2893. PubMed
  193. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  194. Hou H, et al. 2021. Front Cell Dev Biol. 9:737003. PubMed
  195. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  196. Liang P, et al. 2022. Mol Biomed. 3:14. PubMed
  197. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  198. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  199. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  200. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  201. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  202. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  203. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  204. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  205. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  206. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  207. Zong Z, et al. 2019. Front Immunol. 10:1643. PubMed
  208. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  209. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  210. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  211. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  212. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  213. Shen Y, et al. 2022. CNS Neurosci Ther. 28:46. PubMed
  214. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  215. Gao H, et al. 2021. Cells. 10:. PubMed
  216. Saitoh BY, et al. 2021. Brain Behav Immun. 95:362. PubMed
  217. Marks KE, et al. 2021. Cell Reports. 35(13):109303. PubMed
  218. Ohgomori T, et al. 2020. Neuropharmacology. 176:108227. PubMed
  219. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  220. Köchl R, et al. 2020. Elife. 9:00. PubMed
  221. Lin D, et al. 2015. Proc Natl Acad Sci U S A. 112: 11324-11329. PubMed
  222. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  223. Ippolito G, et al. 2014. Proc Natl Acad Sci U S A. 111:998. PubMed
  224. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  225. Perez–Zsolt D, et al. 2019. Front Immunol. 0.989583333. PubMed
  226. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  227. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  228. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  229. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  230. Yuan F, et al. 2022. Front Immunol. 13:798583. PubMed
  231. Forbester JL, et al. 2020. J Virol. 94:. PubMed
  232. Wu H, et al. 2022. Biomolecules. 12:. PubMed
  233. Koivisto CS, et al. 2020. Neoplasia. 1.252777778. PubMed
  234. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  235. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  236. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  237. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  238. Dong S, et al. 2021. Nature. 591:117. PubMed
  239. Tan A, et al. 2012. Mol Pharmacol. 9:2710. PubMed
  240. Cappello P, et al. 2013. Gastroenterology. 144:1098. PubMed
  241. Meraz I, et al. 2014. PLoS One. 9:94703. PubMed
  242. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  243. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  244. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  245. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  246. Yee PP, et al. 2020. Nat Commun. 4.225. PubMed
  247. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  248. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  249. Wang F, et al. 2018. Carcinogenesis. 39:889. PubMed
  250. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  251. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  252. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  253. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  254. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  255. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  256. Yadav P, et al. 2021. J Immunol. 206:2888. PubMed
  257. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  258. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  259. Bao C, et al. 2021. Infect Immun. 89:. PubMed
  260. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  261. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  262. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  263. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  264. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  265. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  266. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  267. Wang Q, et al. 2018. Nat Commun. 9:559. PubMed
  268. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  269. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  270. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  271. Shiraki N, et al. 2022. Stem Cell Reports. 17:221. PubMed
  272. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  273. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  274. Riedelberger M, et al. 2020. Bio Protoc. e3552:10. PubMed
  275. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  276. Miller S, et al. 2016. Acta Biochim Biophys Sin. 48: 334-341. PubMed
  277. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  278. Nishida J, et al. 2022. STAR Protoc. 3:101306. PubMed
  279. Cho K, et al. 2021. iScience. 24:103117. PubMed
  280. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  281. Bakker W, et al. 2021. Int J Mol Sci. 22:. PubMed
  282. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  283. Shan C, et al. 2021. Front Immunol. 12:766401. PubMed
  284. Sobecki M, et al. 2021. Nat Commun. 12:4700. PubMed
  285. Lei J, et al. 2021. Theranostics. 4251:11. PubMed
  286. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  287. Chen X, et al. 2016. PLoS One. 11:e0168861. PubMed
  288. Uto T, et al. 2016. Nat Commun. 7: 11273. PubMed
  289. Leon-Rico D, et al. 2015. Lab Anim. 49:132. PubMed
  290. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  291. Simões FC, et al. 2020. Nat Commun. 0.875. PubMed
  292. Ku AT et al. 2017. eLife. 6 pii: e23242. PubMed
  293. Dong L, et al. 2022. Cells. 11:. PubMed
  294. Li Y, et al. 2022. Front Cardiovasc Med. 9:830781. PubMed
  295. Tang C, et al. 2021. Theranostics. 11:9791. PubMed
  296. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  297. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  298. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  299. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  300. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  301. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  302. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  303. Ding X, et al. 2015. J Immunol. 194:4251. PubMed
  304. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  305. Liu D, et al. 2020. Front Pharmacol. 11:204. PubMed
  306. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  307. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  308. Jäger M, et al. 2018. Antioxid Redox Signal. 30. PubMed
  309. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  310. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  311. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  312. Liu P, et al. 2022. iScience. 25:103867. PubMed
  313. Vasudevan SO, et al. 2022. Cell Rep. 39:110755. PubMed
  314. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  315. Niemi JP, et al. 2020. Methods Mol Biol. 2143:207. PubMed
  316. Dionisio-Santos DA, et al. 2021. Front Neurosci. 15:758677. PubMed
  317. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  318. Dong R, et al. 2021. Frontiers in Immunology. 12:620238. PubMed
  319. Chen S, et al. 2020. Allergy Asthma Immunol Res. 0.922222222. PubMed
  320. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  321. Chen F, et al. 2016. J Immunol. 196: 4390 - 4399. PubMed
  322. Zhuo Y, et al. 2018. Oncol Rep. 40:2147. PubMed
  323. Ponzetta A, et al. 2020. Cell. 178(2):346-360.e24.. PubMed
  324. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  325. Lima-Junior D, et al. 2017. J Immunol. 10.4049/jimmunol.1700258. PubMed
  326. Stevenson ER, et al. 2022. J Pharmacol Exp Ther. 382:356. PubMed
  327. Chen Y, et al. 2022. Life Sci. 306:120826. PubMed
  328. Yamamuro T, et al. 2020. Nat Commun. 3.340277778. PubMed
  329. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  330. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  331. Ostapoff K, et al. 2013. Mol Cancer Ther. 12:1190. PubMed
  332. Macagno M, et al. 2014. J Immunol. 192:5434. PubMed
  333. Chou H, et al. 2015. Proc Natl Acad Sci U S A. 112:2175. PubMed
  334. Quan S, et al. 2015. J Immunol. 194:4175. PubMed
  335. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  336. Li S, et al. 2019. Front Neurol. 1.036805556. PubMed
  337. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  338. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  339. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  340. Ohgomori T et al. 2019. J Comp Neurol. 528(1):14-31 . PubMed
  341. Hua X, et al. 2021. Front Immunol. 12:706027. PubMed
  342. Feng L, et al. 2022. Signal Transduct Target Ther. 7:21. PubMed
  343. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  344. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  345. Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed
  346. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  347. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  348. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  349. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  350. Kitamura K, et al. 2019. Int J Cardiol Heart Vasc. 23:100344. PubMed
  351. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  352. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  353. Alter C et al. 2019. Am J Physiol Heart Circ Physiol. 317(1):H190-H200 . PubMed
  354. Spolski R et al. 2019. Elife. 8 pii: e45501. PubMed
  355. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  356. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  357. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  358. Zhang GL, et al. 2020. Matrix Biol. 93:25. PubMed
  359. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  360. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  361. Mihalik NE, et al. 2021. AAPS PharmSciTech. 22:191. PubMed
  362. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  363. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  364. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  365. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  366. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  367. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  368. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  369. Erin N, et al. 2015. Brain Behav Immun. 48: 174-185. PubMed
  370. Fox D, et al. 2020. Nat Commun. 0.986111111. PubMed
  371. Deng M, et al. 2019. J Exp Med. 216:2838. PubMed
  372. Chan JY, et al. 2019. Diabetologia. 62:993. PubMed
  373. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  374. Glodde N et al. 2017. Immunity. 47(4):789-802 . PubMed
  375. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  376. Adzika GK, et al. 2021. Front Cell Dev Biol. 9:719351. PubMed
  377. Tang S, et al. 2022. Virol J. 19:32. PubMed
  378. Cui Y, et al. 2022. Front Oncol. 12:732860. PubMed
  379. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  380. Tähtinen S, et al. 2022. Nat Immunol. 23:532. PubMed
  381. Patel C, et al. 2022. Curr Protoc. 2:e400. PubMed
  382. Chen J, et al. 2021. Oncol Lett. 21:409. PubMed
  383. Liu SS, et al. 2021. Immunity. :. PubMed
  384. Zhou JH, et al. 2020. Onco Targets Ther. 7.278472222. PubMed
  385. Sitapara RA, et al. 2020. Mol Med. 26:63. PubMed
  386. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  387. Zhong B, et al. 2013. Sci Signal. 6:35. PubMed
  388. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
  389. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  390. Calvente CJ, et al. 2019. J Clin Invest. 130:4091. PubMed
  391. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  392. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  393. Uehara M, et al. 2019. Sci Rep. 9:6535. PubMed
  394. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  395. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
  396. Wang X, et al. 2022. Elife. 11:. PubMed
  397. Adzika GK, et al. 2021. Front Cardiovasc Med. 8:719805. PubMed
  398. Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
  399. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  400. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  401. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  402. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  403. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  404. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  405. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  406. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  407. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  408. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
  409. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  410. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  411. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  412. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  413. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  414. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  415. Palma A, et al. 2022. Front Cell Dev Biol. 10:841548. PubMed
  416. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  417. Xue Y, et al. 2020. Sci Rep. 10:22265. PubMed
  418. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  419. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  420. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  421. Koronyo Y, et al. 2015. Brain. 138: 2399-2422. PubMed
  422. Zhao Y, et al. 2013. J Leukoc Biol. 94:1103. PubMed
  423. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  424. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  425. Moriyasu T, et al. 2018. PLoS Negl Trop Dis. 12:e0006197. PubMed
  426. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  427. Wang S, et al. 2022. Blood. 140:171. PubMed
  428. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  429. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  430. Wu KKL, et al. 2021. Nat Commun. 12:6637. PubMed
RRID
AB_312789 (BioLegend Cat. No. 101206)
AB_312788 (BioLegend Cat. No. 101205)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD11b
Specificity Alt (DOES NOT SHOW ON TDS):
CD11b
App Abbreviation (DOES NOT SHOW ON TDS):
FC
Hidden Names (DOES NOT SHOW ON TDS):
aM integrin, alpha integrin, alphaM integrin, alpha M integrin, integrin alphaM, integrin aM, integrin alpha M, CD11, Macrophage, Myeloid Dendritic Cell, Neutrophil, NK Cell, Plasmacytoid Dendritic Cell, Microglia
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS B550™ anti-mouse/human CD11b M1/70 FC
Spark YG™ 581 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
StarBright UltraViolet 575 anti-mouse/human CD11b M1/70 FC
StarBright UltraViolet 740 anti-mouse/human CD11b M1/70 FC
Spark PLUS V475™ anti-mouse/human CD11b M1/70 FC
Spark PLUS V450™ anti-mouse/human CD11b M1/70 FC
Spark PLUS YG581™ anti-mouse/human CD11b M1/70 FC
Go To Top Version: 1    Revision Date: 11-30-2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account